Question 1

What are the potential side effects of B019?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma. clinical trial (NCT06970496). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma. clinical trial (NCT06970496). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment process look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma. clinical trial (NCT06970496). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks I should be aware of before participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma. clinical trial (NCT06970496). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma. clinical trial (NCT06970496). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma. clinical trial (NCT06970496). Contact the study team or your healthcare provider for specific answers.

What this study is about